NM_006453.3:c.316G>A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_006453.3(TBL3):c.316G>A(p.Ala106Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,611,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006453.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152250Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000843 AC: 21AN: 249172Hom.: 0 AF XY: 0.0000741 AC XY: 10AN XY: 135042
GnomAD4 exome AF: 0.000120 AC: 175AN: 1458930Hom.: 0 Cov.: 36 AF XY: 0.000125 AC XY: 91AN XY: 725328
GnomAD4 genome AF: 0.000125 AC: 19AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.316G>A (p.A106T) alteration is located in exon 5 (coding exon 5) of the TBL3 gene. This alteration results from a G to A substitution at nucleotide position 316, causing the alanine (A) at amino acid position 106 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at